Werner Scheithauer
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 216
- Colorectal Cancer Treatments and Studies 116
- Cancer Treatment and Pharmacology 60
- Pancreatic and Hepatic Oncology Research 44
-
- Gastric Cancer Management and Outcomes 28
- Lung Cancer Treatments and Mutations 18
- Co-authors
- Gabriela Verena Kornek (92 shared papers)Arié Figer (7 shared papers)Dieter Depisch (54 shared papers)Markus Raderer (49 shared papers)Eduardo Díaz‐Rubio (6 shared papers)Stephen John Clarke (4 shared papers)Sheryl L. Koski (4 shared papers)Leonard B. Saltz (4 shared papers)
- Journals
- Annals of Oncology (50 papers)Journal of Clinical Oncology (22 papers)British Journal of Cancer (22 papers)European Journal of Cancer (21 papers)Oncology (13 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Werner Scheithauer
308 papers receiving 26.6k citations
Werner Scheithauer's Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 17.0k
- Hepatology 4.7k
- Cancer Research 2.6k
- Pulmonary and Respiratory Medicine 4.5k
- Pathology and Forensic Medicine 2.5k
Countries citing papers authored by Werner Scheithauer
This map shows the geographic impact of Werner Scheithauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Scheithauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Scheithauer more than expected).
Fields of papers citing papers by Werner Scheithauer
This network shows the impact of papers produced by Werner Scheithauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Scheithauer. The network helps show where Werner Scheithauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Scheithauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Hit paper breakdown → | 2016 | 2659 |
| 2 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study Hit paper breakdown → | 2008 | 2480 |
| 3 | Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Hit paper breakdown → | 2008 | 1531 |
| 4 | FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2014 | 1433 |
| 5 | ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Hit paper breakdown → | 2012 | 1219 |
| 6 | Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Hit paper breakdown → | 2013 | 996 |
| 7 | Capecitabine as Adjuvant Treatment for Stage III Colon Cancer Hit paper breakdown → | 2005 | 990 |
| 8 | EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 778 |
| 9 | Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 724 |
| 10 | Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer Hit paper breakdown → | 2009 | 667 |
| 11 | nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial Hit paper breakdown → | 2015 | 565 |
| 12 | 2009 | 558 | |
| 13 | Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study Hit paper breakdown → | 2015 | 540 |
| 14 | Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Hit paper breakdown → | 1993 | 533 |
| 15 | 2007 | 499 | |
| 16 | 2002 | 392 | |
| 17 | 2016 | 347 | |
| 18 | 2008 | 344 | |
| 19 | 2012 | 250 | |
| 20 | 2003 | 233 |
About Werner Scheithauer
Werner Scheithauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Pathology and Forensic Medicine and Surgery, having authored 324 papers that have together received 27.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (116 papers), Cancer Treatment and Pharmacology (60 papers), Pancreatic and Hepatic Oncology Research (44 papers), Gastric Cancer Management and Outcomes (28 papers), Neuroendocrine Tumor Research Advances (22 papers), Lung Cancer Treatments and Mutations (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Genetic factors in colorectal cancer (16 papers). The work is most often cited by research in Oncology (17.0k citations), Hepatology (4.7k citations), Cancer Research (2.6k citations), Pulmonary and Respiratory Medicine (4.5k citations) and Pathology and Forensic Medicine (2.5k citations). Werner Scheithauer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Gabriela Verena Kornek, Arié Figer, Dieter Depisch, Markus Raderer, Eduardo Díaz‐Rubio, Stephen John Clarke, Sheryl L. Koski, Leonard B. Saltz, Thomas Gruenberger and Jim Cassidy. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.